All Phenotypes Casz1<tm1.1Flc> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Casz1^tm1.1Flc/Casz1^tm1.1Flc Nkx2-5^tm1(cre)Rjs/Nkx2-5⁺	involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL	MGI:5811822
cn2	Casz1^tm1.1Flc/Casz1⁺ Nkx2-5^tm1(cre)Rjs/Nkx2-5⁺	involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL	MGI:5811817
cn3	Casz1^tm1.1Flc/Casz1^tm1.1Flc Isl1^tm1(cre)Tmj/Isl1⁺	involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL	MGI:5811826
cn4	Casz1^tm1.1Flc/Casz1^tm1.1Flc Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺	involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA * SJL	MGI:5811819

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality during organogenesis, complete penetrance ( J:221324 )

• no viable embryos are identified after E14.5

• however, embryos appear grossly normal at E12.5

homeostasis/metabolism

edema ( J:221324 )

• severe edema at E13.5

cardiovascular system

thin myocardium ( J:221324 )

• severe thinning of the myocardium by E12.5

abnormal heart development ( J:221324 )

• abnormal heart development between E10.5 and E12.5

decreased fetal cardiomyocyte number ( J:221324 )

• at E12.5, the number of tropomyosin (TMY)-positive cardiomyocytes is significantly reduced in the ventricles

• however, no increase in programmed cell death is observed and actin filaments are intact

abnormal heart apex morphology ( J:221324 )

• heart fails to form an apex for either the left or the right ventricle

increased heart right atrium size ( J:221324 )

• enlarged right atrium at E12.5; more pronounced at E13.5

dilated heart right atrium ( J:221324 )

• ballooning of the right atria by E13.5, indicating blood pooling in the right ventricle

abnormal heart shape ( J:221324 )

• misshapen heart at E13.5

heart hypoplasia ( J:221324 )

• severe cardiac hypoplasia by E13.5

• at E12.5, cardiac hypoplasia is specific to cardiomyocytes and does not affect the epicardium or endothelial cells

abnormal heart ventricle morphology ( J:221324 )

• narrower ventricular lumens by E13.5

trabecula carnea hypoplasia ( J:221324 )

• decreased trabeculation at E12.5

abnormal interventricular septum morphology ( J:221324 )

• underdeveloped interventricular septum at E12.5

perimembraneous ventricular septal defect ( J:221324 )

• membranous ventricular septal defects by E13.5

abnormal heart left ventricle morphology ( J:221324 )

• malformed left ventricle at E12.5; more pronounced at E13.5

thin ventricular wall ( J:221324 )

• thinning of the ventricular walls starting at E12.5

distended pericardium ( J:221324 )

• inflated pericardial sacs at E13.5

hemorrhage ( J:221324 )

• severe blood hemorrhaging at E13.5

poor circulation ( J:221324 )

• decreased blood flow throughout the vasculature by E13.5

abnormal fetal cardiomyocyte physiology ( J:221324 )

• at E12.5, the G1-to-S phase progression of cardiomyocytes is impaired, as shown by a prolonged or arrested G1 phase, a reduction in DNA synthesis, an increase in phospho-RB, and a decrease in the cardiac mitotic index

decreased fetal cardiomyocyte proliferation ( J:221324 )

• cardiomyocyte proliferation is significantly reduced in E12.5 ventricles, as shown by EdU incorporation

cellular

decreased fetal cardiomyocyte proliferation ( J:221324 )

• cardiomyocyte proliferation is significantly reduced in E12.5 ventricles, as shown by EdU incorporation

abnormal cell cycle checkpoint function ( J:221324 )

• at E12.5, cell cycle profiling of cardiac nuclei revealed a significant increase of cells in G1 phase and a simultaneous decrease of cells in S phase, with no alteration in the % of cells in G2 phase

decreased mitotic index ( J:221324 )

• cardiomyocyte mitotic index is significantly reduced in E12.5 ventricles, as shown by phospho-histone H3 staining

muscle

trabecula carnea hypoplasia ( J:221324 )

• decreased trabeculation at E12.5

thin myocardium ( J:221324 )

• severe thinning of the myocardium by E12.5

decreased fetal cardiomyocyte proliferation ( J:221324 )

• cardiomyocyte proliferation is significantly reduced in E12.5 ventricles, as shown by EdU incorporation

Allelic Composition	Casz1^tm1.1Flc/Casz1⁺ Nkx2-5^tm1(cre)Rjs/Nkx2-5⁺
Genetic Background	involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Casz1^tm1.1Flc mutation (1 available); any Casz1 mutation (342 available)
Nkx2-5^tm1(cre)Rjs mutation (1 available); any Nkx2-5 mutation (22 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

normal phenotype

no abnormal phenotype detected ( J:221324 )

• mice are viable, fertile and show no obvious phenotypic abnormalities

Allelic Composition	Casz1^tm1.1Flc/Casz1^tm1.1Flc Isl1^tm1(cre)Tmj/Isl1⁺
Genetic Background	involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Casz1^tm1.1Flc mutation (1 available); any Casz1 mutation (342 available)
Isl1^tm1(cre)Tmj mutation (0 available); any Isl1 mutation (38 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

lethality throughout fetal growth and development, complete penetrance ( J:221324 )

• embryos are viable and indistinguishable from controls at least until E14.5; however, no mice are recovered postnatally

cardiovascular system

abnormal heart shape ( J:221324 )

• misshapen heart at E14.5

• however, no ventricular septal defects are detected at E14.5

abnormal heart right ventricle morphology ( J:221324 )

• right ventricular wall thickness is significantly reduced at E14.5

• however, left ventricular wall thickness is normal

heart right ventricle hypoplasia ( J:221324 )

• right ventricular hypoplasia at E14.5

cellular

decreased mitotic index ( J:221324 )

• at E12.5, cardiomyocyte mitotic index is significantly reduced in the right ventricles (but not in the left ventricles), as shown by phospho-histone H3 staining

Allelic Composition	Casz1^tm1.1Flc/Casz1^tm1.1Flc Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺
Genetic Background	involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Casz1^tm1.1Flc mutation (1 available); any Casz1 mutation (342 available)
Edil3^{Tg(Sox2-cre)1Amc} mutation (5 available); any Edil3 mutation (44 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality during organogenesis, complete penetrance ( J:221324 )

• embryos do not survive past E14.5

cardiovascular system

abnormal heart development ( J:221324 )

• at E12.5, embryos show a cardiac phenotype indistinguishable from that of embryos homozygous for Casz1^tm1.1Flc and heterozygous for Nkx2-5^tm1(cre)Rjs

ventricular septal defect ( J:221324 )

• at E12.5

heart hypoplasia ( J:221324 )

• severe cardiac hypoplasia at E12.5

thin ventricular wall ( J:221324 )

• at E12.5

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 09/08/2026 MGI 6.24